145
Participants
Start Date
June 30, 2008
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
ABT-869
12.5 mg ABT-869
Placebo for ABT-869
Placebo Comparator (12.5 mg or 7.5 mg)
ABT-869
7.5 mg ABT-869
Carboplatin
Carboplatin (AUC 6 mg/mL/min)
Paclitaxel
Paclitaxel (200 mg/m2)
Site Reference ID/Investigator# 21862, Lismore
Site Reference ID/Investigator# 23682, Cairns
Site Reference ID/Investigator# 19043, Woodville South
Site Reference ID/Investigator# 19042, Bedford Park
Site Reference ID/Investigator# 18962, Prague
Site Reference ID/Investigator# 13101, Philadelphia
Site Reference ID/Investigator# 24122, Philadelphia
Site Reference ID/Investigator# 19022, Pribram V
Site Reference ID/Investigator# 15848, Greensboro
Site Reference ID/Investigator# 7179, Atlanta
Site Reference ID/Investigator# 15841, Miami
Site Reference ID/Investigator# 15847, Cleveland
Site Reference ID/Investigator# 22444, Canton
Site Reference ID/Investigator# 15851, Lansing
Site Reference ID/Investigator# 22504, Náchod
Site Reference ID/Investigator# 18964, Kyjov
Site Reference ID/Investigator# 18963, Olomouc
Site Reference ID/Investigator# 15850, Chandler
Site Reference ID/Investigator# 15846, Peoria
Site Reference ID/Investigator# 18064, Moscow
Site Reference ID/Investigator# 18065, Moscow
Site Reference ID/Investigator# 23312, Moscow
Site Reference ID/Investigator# 18961, Singapore
Site Reference ID/Investigator# 18066, Moscow
Site Reference ID/Investigator# 23562, Saint Petersburg
Site Reference ID/Investigator# 38003, Kazan'
Site Reference ID/Investigator# 38260, Kirov
Site Reference ID/Investigator# 15844, Lebanon
Site Reference ID/Investigator# 22443, Hackensack
Site Reference ID/Investigator# 26842, Hershey
Site Reference ID/Investigator# 17703, Jaú
Site Reference ID/Investigator# 23522, Porto Alegre
Site Reference ID/Investigator# 15601, Porto Alegre
Site Reference ID/Investigator# 17704, Rio de Janeiro
Site Reference ID/Investigator# 22684, Santo André
Site Reference ID/Investigator# 17702, São Paulo
Site Reference ID/Investigator# 23582, São Paulo
Collaborators (1)
Genentech, Inc.
INDUSTRY
AbbVie (prior sponsor, Abbott)
INDUSTRY